|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - EAGLE PHARMACEUTICALS Inc (EGRX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In
Common stock purchase or sale:
| Transaction Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2017-08-16 Purchase |
2017-08-16 8:30 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. Chief Financial Officer |
350 | $55.45 | $19,406 | 700 (Direct) |
View |
| 2017-08-09 Purchase |
2017-08-11 4:34 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director |
20,400 | $49.07 | $1,001,087 | 971,000 (Indirect) |
View |
| 2017-06-12 Purchase |
2017-06-12 4:46 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. Chief Financial Officer |
350 | $71.49 | $25,021 | 350 (Direct) |
View |
| 2017-05-19 Purchase |
2017-05-19 4:42 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
255 | $79.69 | $20,321 | 966 (Direct) |
View |
| 2017-05-16 Purchase |
2017-05-16 5:37 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
200 | $82.24 | $16,448 | 711 (Direct) |
View |
| 2017-04-25 Sale |
2017-04-27 4:19 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
54,180 | $88.38 | $4,788,482 | 3,584,087 (Indirect) |
View |
| 2017-03-30 Sale |
2017-04-03 5:22 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
91,332 | $83.09 | $7,589,014 | 3,669,196 (Indirect) |
View |
| 2017-03-27 Sale |
2017-03-29 5:34 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
106,468 | $83.01 | $8,837,576 | 3,740,356 (Indirect) |
View |
| 2017-03-22 Sale |
2017-03-24 4:41 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
14,125 | $81.07 | $1,145,130 | 15,000 (Direct) |
View |
| 2017-03-21 Sale |
2017-03-23 5:02 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
1,200 | $83.05 | $99,657 | 3,778,787 (Indirect) |
View |
| 2017-03-22 Purchase |
2017-03-22 4:47 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director |
6,000 | $79.44 | $476,640 | 29,400 (Direct) |
View |
| 2017-03-21 Purchase |
2017-03-21 4:37 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
61 | $83.98 | $5,123 | 511 (Direct) |
View |
| 2017-03-16 Sale |
2017-03-20 5:40 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
100,000 | $82.06 | $8,206,308 | 3,870,167 (Indirect) |
View |
| 2017-03-09 Purchase |
2017-03-10 7:20 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
450 | $77.84 | $35,028 | 450 (Direct) |
View |
| 2017-01-04 Sale |
2017-01-06 4:39 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
65,114 | $85.16 | $5,545,108 | 3,879,287 (Indirect) |
View |
| 2016-12-15 Sale |
2017-01-04 7:19 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
50,505 | $76.4 | $3,858,622 | 63,717 (Direct) |
View |
| 2016-12-13 Sale |
2016-12-15 4:57 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
10,000 | $73.62 | $736,163 | 10,000 (Direct) |
View |
| 2014-04-03 Purchase |
2016-12-14 4:29 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
3,950 | $12.79 | $50,520 | 23,324 (Direct) |
View |
| 2014-04-03 Sale |
2016-12-14 4:29 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
10,000 | $75.01 | $750,091 | 23,324 (Direct) |
View |
| 2016-11-23 Sale |
2016-12-02 8:56 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,987 | $80 | $478,960 | 19,210 (Direct) |
View |
| 2016-11-28 Sale |
2016-11-30 5:12 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
5,000 | $78.66 | $393,300 | 11,374 (Direct) |
View |
| 2016-11-10 Sale |
2016-11-14 5:40 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
34,486 | $85.15 | $2,936,605 | 3,961,919 (Indirect) |
View |
| 2016-11-07 Sale |
2016-11-09 5:52 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
153,830 | $79.29 | $12,197,276 | 4,126,087 (Indirect) |
View |
| 2016-11-02 Sale |
2016-11-04 5:07 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
245,770 | $71.02 | $17,455,385 | 4,227,616 (Indirect) |
View |
| 2016-09-30 Sale |
2016-10-04 4:20 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
22,100 | $70.06 | $1,548,326 | 4,373,987 (Indirect) |
View |
| 2016-09-29 Sale |
2016-09-30 4:15 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
77,900 | $70.04 | $5,456,116 | 4,396,087 (Indirect) |
View |
| 2016-09-21 Sale |
2016-09-23 5:15 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
99,795 | $66.17 | $6,603,416 | 4,475,785 (Indirect) |
View |
| 2016-09-06 Sale |
2016-09-08 5:01 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
70,925 | $62.5 | $4,432,863 | 4,630,299 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported Date |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2017-05-15 Option Award |
2017-05-15 7:28 pm |
N/A 2027-05-14 |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. Chief Financial Officer |
50,000 | $82.3 | 50,000 (Direct) |
View |
| 2017-05-15 Other |
2017-05-15 08:39 am |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
3,584,087 | $0 | 172,381 (Indirect) |
View |
| 2017-05-15 Other |
2017-05-15 08:39 am |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
149,107 | $0 | 172,381 (Indirect) |
View |
| 2017-05-15 Other |
2017-05-15 08:39 am |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
149,107 | $0 | 172,381 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $0.9 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $4.04 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
3,120 | $4.42 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
9,360 | $12.67 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
10,000 | $46.09 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
20,000 | $59.31 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2012-03-06 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $0.9 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2013-03-06 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $4.04 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2014-03-06 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2015-07-12 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2016-06-29 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
2,340 | $8.78 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2016-06-29 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
3,120 | $4.42 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2015-04-08 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
9,360 | $12.67 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2016-03-13 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
10,000 | $46.09 | 3,584,087 (Indirect) |
View |
| 2017-04-25 Exercise |
2017-04-27 4:19 pm |
2016-04-21 2017-06-29 |
EAGLE PHARMACEUTICALS Inc | EGRX | ProQuest Investments IV L.P. ProQuest Financial LLC ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
20,000 | $59.31 | 3,584,087 (Indirect) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,023 | $4.42 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,077 | $12.67 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,025 | $12.67 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,000 | $12.63 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A 2023-04-18 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,023 | $4.42 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A 2024-04-07 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,077 | $12.67 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A 2024-04-07 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,025 | $12.67 | 15,000 (Direct) |
View |
| 2017-03-22 Exercise |
2017-03-24 4:41 pm |
N/A 2024-08-25 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,000 | $12.63 | 15,000 (Direct) |
View |
| 2017-03-17 Option Award |
2017-03-21 4:36 pm |
N/A 2027-03-16 |
EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director |
10,000 | $81.27 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:25 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | RIGGS DAVID E Chief Financial Officer |
40,000 | $84.92 | 40,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:16 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Graves Michael Director |
10,000 | $84.92 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:15 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Glenning Robert Director |
10,000 | $84.92 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:15 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
10,000 | $84.92 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:10 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
10,000 | $84.92 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:10 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO Director |
200,900 | $84.92 | 200,900 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:08 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
42,000 | $84.92 | 42,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:08 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director |
10,000 | $84.92 | 10,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:08 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
90,000 | $84.92 | 90,000 (Direct) |
View |
| 2017-01-04 Option Award |
2017-01-06 5:05 pm |
N/A 2027-01-03 |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
67,200 | $84.92 | 67,200 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
3,730 | $4.42 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
6,270 | $12.67 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,683 | $12.67 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
7,317 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
10,000 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,683 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
7,569 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,126 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,127 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2023-04-18 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
3,730 | $4.42 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2024-04-07 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
6,270 | $12.67 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2024-04-07 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,683 | $12.67 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2024-08-25 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
7,317 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2024-08-25 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
10,000 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2024-08-25 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,683 | $12.63 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2025-03-12 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
7,569 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2025-03-12 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,126 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-15 Exercise |
2017-01-04 7:19 pm |
N/A 2025-03-12 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
5,127 | $46.09 | 63,717 (Direct) |
View |
| 2016-12-13 Exercise |
2016-12-15 4:57 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
10,000 | $4.42 | 10,000 (Direct) |
View |
| 2016-12-13 Exercise |
2016-12-15 4:57 pm |
N/A 2023-04-18 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
10,000 | $4.42 | 10,000 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
200 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
1,950 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,530 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
1,307 | $4.42 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A 2022-07-11 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
200 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A 2021-09-25 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
1,950 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A 2022-07-11 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
2,530 | $8.78 | 19,210 (Direct) |
View |
| 2016-11-23 Exercise |
2016-12-02 8:56 pm |
N/A 2023-04-18 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
1,307 | $4.42 | 19,210 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Mon, 21 May 2018 23:35:44 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |